LOSS OF CAR T-CELL PERSISTENCE

This adverse event was reported 30 times

LOSS OF CAR T-CELL PERSISTENCE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DASATINIB 7 0.0008
1 ETOPOSIDE PHOSPHATE 1 0.0006
2 CILTACABTAGENE AUTOLEUCEL 4 0.0006
3 CYTARABINE 7 0.0001
4 TOCILIZUMAB 1 0.0000
5 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
6 CYCLOPHOSPHAMIDE 1 0.0000
7 ACETAMINOPHEN 1 0.0000
8 PREDNISONE 1 0.0000
See all drugs enriched for association with LOSS OF CAR T-CELL PERSISTENCE

LOSS OF CAR T-CELL PERSISTENCE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nucleoside Metabolic Inhibitor [EPC] 7 0.0000
1 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
2 Alkylating Drug [EPC] 1 0.0000
3 Corticosteroid [EPC] 1 0.0000
4 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with LOSS OF CAR T-CELL PERSISTENCE